Molecular detection of African horse sickness virus from selected areas in Ethiopia Authors: Degu Fhetanegest Esey, Hika Waktole, Esayas Gelaye, Dessalew Habte Alene, Habtamu Addis Minale Published: 2026 ABSTRACT Highlights•Equines play a crucial role in supporting global economies and sustaining millions of livelihoods, particularly in developing countries such as Ethiopia. However, their productivity and welfare are significantly compromised by infectious diseases, with African Horse Sickness (AHS) being one of the most devastating, causing severe socio-economic losses. A cross-sectional study conducted from November 2022 to May 2023 investigated the presence of African horse sickness virus (AHSV) in epidemic-prone areas of Ethiopia. A total of 30 blood samples and 2 tissue specimens were collected from clinically sick and recently dead equines and transported under cold chain conditions to the National Veterinary Institute in Bishoftu for laboratory analysis.•All 32 samples were examined using conventional RT-PCR targeting the Viral Protein 7 (VP7) gene, resulting in 7 positive samples (21.88%) that produced the expected 102 bp amplification product. Further serotyping using Viral Protein 2 (VP2) gene-specific primers identified AHSV serotype 9, detected exclusively in tissue samples, which showed a 228 bp band. Virus isolation on Vero cell cultures from tissue samples demonstrated cytopathic effects including cell aggregation, rounding, and detachment, confirming viral activity. The findings indicate that AHSV serotype 9 is a major circulating strain responsible for severe disease and high mortality in horses in Ethiopia. The study emphasizes the importance of strategic vaccination, enhanced surveillance, and further molecular and epidemiological investigations to better understand virus circulation in equines and insect vectors.Keywords: AHS, Horse, Molecular detection, RT-PCR, Serotype – 9 Introduction Globally, equines are widely distributed and play essential roles in agriculture, transport, and rural livelihoods, although their productivity is increasingly threatened by infectious diseases such as African horse sickness (AHS). AHS is a severe, arthropod-borne viral disease caused by African horse sickness virus (AHSV), an Orbivirus with a segmented double-stranded RNA genome, characterized by high mortality in susceptible equids and transmission mainly via Culicoides biting midges (Stringer et al., 2015; Ma et al., 2024; WOAH, 2024). The disease is endemic across Sub-Saharan Africa and parts of East Africa, with nine recognized serotypes circulating worldwide, complicating control strategies due to limited cross-protection between strains (Meiswinkel and Paweska, 1999; Carpenter et al., 2017; Schliewert et al., 2022). In Africa, AHS remains a major transboundary equine disease, with historical and recent outbreaks demonstrating repeated viral circulation and expansion driven by vector ecology and climatic factors. Ethiopia, which hosts the second-largest equine population globally, has experienced multiple AHSV outbreaks over the past decades, with documented circulation of several serotypes including AHSV-2, -4, -6, -8, and -9, where serotype 9 has been most frequently reported in different outbreak years (Aklilu et al., 2014, Ayelet et al., 2014). These findings highlight the epidemiological complexity of AHSV in Ethiopia and underscore its continuing threat to equine health and rural livelihoods in endemic regions (Adesola et al., 2023; WOAH, 2024). African horse sickness virus (AHSV) has a long history of sporadic outbreaks in Ethiopia, where multiple serotypes have been suspected based on serological and limited molecular evidence, indicating ongoing endemic circulation with periodic epizootic spread. Reports from 2021-2025 show continued detection of AHSV during suspected outbreaks in equine populations, although detailed serotype mapping and full genomic characterization remain limited in many investigations. Overall, recent studies emphasize that the epidemiology of AHSV in Ethiopia is still incompletely defined, with gaps in systematic surveillance and strain-level identification that hinder comprehensive understanding of circulating serotypes and transmission dynamics (Quinn et al., 2011; World Organization for Animal Health (WOAH), 2024). Molecular detection and serotyping of AHSV in Ethiopia are essential because clinical diagnosis alone is unreliable and multiple serotypes may co-circulate during outbreaks. RT-PCR enables rapid and sensitive confirmation of infection, while serotyping identifies circulating strains, which is critical for outbreak characterization, vaccine selection, and epidemiological understanding. Given the limited molecular data available in Ethiopia, integrating these tools strengthens surveillance and improves evidence-based control strategies (Carpenter, 2017; WOAH, 2024). In Ethiopia AHS is endemic, with multiple outbreaks reported across different regions and time (Long & Guthrie, 2014; Guthrie, 2018). Between January 2007 and December 2011, the Ministry of Agriculture documented 961 outbreaks, 21,270 cases, and 4,073 deaths nationwide (Aklilu et al., 2014; Ayelet et al., 2014; Guthrie, 2018). Despite the high mortality, current data on circulating serotypes and epidemiological status remain limited. There is a significant gap in molecularly identifying and characterizing epidemic serotypes, which is critical for rapid deployment of effective vaccine strains. Therefore, the objectives of this study were: ➢To isolate and detect African horse sickness virus (AHSV) in selected areas of Ethiopia using virological and molecular methods. To isolate and detect African horse sickness virus (AHSV) in selected areas of Ethiopia using virological and molecular methods. ➢To identify and serotype circulating AHSV strains from field outbreaks. To identify and serotype circulating AHSV strains from field outbreaks. Materials and methods Description of the study area The study was conducted from November 2022 to May 2023 in purposively selected African horse sickness outbreak areas of Ethiopia, including Liben Chukuala (Adulala), Moretna Jiru (Enewri), Negelle Arsi, Goro, Yabello, Kimbibit (Sheno), and Bacho (Jimma) (Fig. 1). These sites are located in the Oromia and Amhara regions and were selected based on reported outbreaks and equine population density (CSA, 2019; CSA, 2020). Map of Ethiopia showing the study areas where samples were collected, (QGIS software version 3.14). Study design and population An outbreak-based cross-sectional study was conducted in equines from purposively selected areas of the Oromia and Amhara regions, selected based on equine population density and active AHS outbreaks. The study population comprised working equines (horses and donkeys), while mules were excluded due to not meeting the selection criteria as they are less susceptible. Sampling included clinically sick and recently dead animals showing typical signs of AHS, regardless of age, sex, breed, or body condition. For analysis, age was categorized into ≤3 years (young), 4-10 years (adult), and >10 years (old), and all animals were sourced from diseased cases reported by owners in the study areas. Sample collection, transportation and storage Whole blood (n = 30) and representative tissue samples (lung and spleen, n = 2) were aseptically collected from clinically sick and recently dead equines suspected of African horse sickness (AHS). Blood (10mL) was collected via jugular venipuncture into EDTA vacutainer tubes, while tissue samples were placed in sterile bottles containing viral transport medium composed of glycerol and phosphate-buffered saline with antibiotics and antifungals. All samples were properly labeled, transported under a cold chain to the National Veterinary Institute (NVI), Bishoftu, Ethiopia, and stored at -80°C following OIE guidelines (OIE (World Organization of Animal Health), 2019; WOAH, 2024). Sample processing and RNA extraction Tissue samples were thawed, homogenized, and centrifuged to obtain clarified supernatants. Viral RNA was extracted from 100µL of whole blood and tissue suspension using the QIAamp Viral RNA Mini Kit (Qiagen, USA) according to the manufacturer’s instructions. The extraction process involved lysis with buffer, ethanol addition, column-based binding, washing steps with RW1 and RPE buffers, and final elution with RNase-free water. Extracted RNA was stored at 4°C for short-term use and -70°C for long-term preservation prior to molecular analysis based on Fernández-Pinero et al. (2009) and Weyer et al. (2015). Molecular detection and serotyping Molecular detection of AHSV was performed using one-step conventional reverse transcription PCR (RT-PCR) targeting a conserved region of the VP7 gene (segment 7), which is common to all nine serotypes and used for general virus detection (Agüero et al., 2008; Weyer et al., 2015). For serotyping, VP2 gene-specific primers targeting segment 2, responsible for antigenic variation, were used to identify circulating AHSV serotypes in outbreak samples. The amplified products were analyzed to confirm infection and determine the serotype distribution of AHSV strains circulating in the study areas based on WOAH, 2024 guide line (Table 1). Table 1Serogroup specific and serotype specific forward and reverse primers used in RT-PCR assay.Table 1 dummy alt textSerotypePrimerSequence (5’-3’)Location (bp)Size of ampliconUniversalForwardGGCTCCAACACTCACAAGATGT1-20102bpReverseGGCGGATTAATAGGCTGCATA1179-1159Serotype 2ForwardAATTGTGATGTTATTGTTAC76-95152bpReverseGGCGAAAAGTACATTTCACC394-371Serotype 4ForwardGTTTAATTCACCATGGCGTC1-20352bpReverseTACATCATTCCAAATCTCAGC666-646Serotype 9ForwardGTTTAATTCACCATGGCGTC1-20228 and 282bpReverseCGTTTGTTTGTACATAAAA2778-2758 Serogroup specific and serotype specific forward and reverse primers used in RT-PCR assay. Master mix preparation and PCR amplification The PCR master mix was prepared according to the manufacturer’s instructions (Qiagen, USA) and scaled for different reaction batches. For VP7 detection, a total of 720µL master mix was prepared for 36 reactions (excluding template RNA), from which 20µL was dispensed into each PCR tube followed by 5µL of extracted RNA. For VP2-based serotyping, 308µL of master mix was prepared for 11 reactions, thoroughly mixed, and 28µL was aliquoted into each tube followed by µL of RNA template. RT-PCR amplification for both assays included reverse transcription at 50°C for 30 minutes and initial denaturation at 95°C for 15min, followed by 40 cycles of denaturation at 95°C for 1min; annealing at 58°C (VP7) or 48°C (VP2) for 1min; and extension at 72°C (VP7) or 70°C (VP2) for 2min, with final extension steps at 70°C for 5min (VP7) and 70°C for 8min (VP2), respectively. The expected amplicon size for VP7 was 102bp. Isolation of AHSV in Vero cells The African green monkey kidney cell line (Vero) (AU-PANVAC, Ethiopia) was used for virus isolation and maintained in 25 cm² tissue culture flasks at the Virology Laboratory of the National Veterinary Institute (NVI), Ethiopia. Cells were monitored daily under an inverted microscope, and once a confluent monolayer (>80%) was achieved, thawed supernatants stored at −80°C were inoculated onto the Vero cell monolayers. Briefly, 1mL of filtered supernatant was inoculated into each of two 25cm² tissue culture flasks, while a third flask containing only maintenance medium served as the negative control. After adsorption for 1 hour at 37°C, 9mL of Glasgow Minimum Essential Medium (GMEM) supplemented with 0.1% gentamicin and 2% fetal calf serum was added. The cultures were then incubated at 37°C and examined daily for 10 days for the development of cytopathic effects (CPE) using an inverted microscope. Data management and analysis Laboratory data were recorded in Microsoft Excel and analyzed using Stata version 17 (StataCorp LLC, College Station, TX, USA). Associations between potential risk factors (origin, age, sex, species, and season) and the occurrence of African horse sickness (AHS) virus isolates were evaluated using Pearson’s chi-square test or Fisher’s exact test, as appropriate. Results Field clinical and necropsy findings Clinical examination of equines suspected of AHS revealed common signs including fever, dyspnea, frothy nasal discharge, depression, sweating, and edema of the head (Fig. 2). Post-mortem examination of two horses that died in Adulala Town revealed characteristic AHS lesions, including severe pulmonary congestion and edema, frothy respiratory exudate with hydrothorax, and petechial hemorrhages on the spleen, heart, and intestinal serosa (Fig. 2D). Clinical signs and post-mortem lesions observed in African horse sickness (AHS)-suspected horses: (A) head and neck edema; (B) conjunctival congestion/hemorrhage with periorbital edema; (C) per-acute death with frothy nasal discharge; and (D) pulmonary edema accompanied by petechial hemorrhages. Molecular detection results and associated risk factors A total of 32 whole blood and tissue samples collected from selected study areas were tested for AHSV using a conventional RT-PCR assay targeting the VP7 gene (segment 7) with universal primers. Of these, 30 were whole blood samples and 2 were tissue samples. Five (16.7%) blood samples and both tissue samples (100%) tested positive, as confirmed by amplification of the expected 102bp PCR product on agarose gel electrophoresis (Fig. 3). Positive samples were subsequently selected for virus isolation and serotyping. Overall, AHSV RNA was detected in 21.9% (7/32) of the samples. Although the detection rate was higher in donkeys (25.0%, 2/8) than in horses (20.8%, 5/24), the difference was not statistically significant (p = 0.85). Similarly, positivity was higher in females (30.0%, 3/10) than in males (18.2%, 4/22). By age, the highest detection rate was observed in older equines (75.0%, 6/8), followed by adults aged 4-10 years (6.7%, 1/15), whereas no AHSV-positive cases were detected in animals younger than 4 years. Agarose gel electrophoresis of RT-PCR products targeting the AHSV VP7 gene (102 bp). Positive bands were detected in lanes 1, 4, 7, 13, 20, 31, and 32; C1–C2 are positive controls, C3–C4 are negative controls, and M is the 100 bp DNA ladder. Comparison of the clinical forms of African horse sickness (AHS) with RT-PCR results showed no significant association between clinical presentation and virus detection (p = 0.299). The highest detection rates were observed in subclinical cases (33.3%, 2/6) and the pulmonary form (33.3%, 1/3), followed by the mixed form (26.7%, 4/15), whereas no AHSV was detected in horses with the cardiac form. Detection rates also varied by study area, with the highest positivity recorded in Adulala (100%), followed by Sheno (50%), Arsi Negele (25%), and Jimma (20%). No AHSV-positive samples were detected in Moretina Juru (Amhara Region), Bale Goro, or Yabello (Oromia Region). Overall, AHSV detection was relatively higher in equids exhibiting respiratory signs (pulmonary form), although differences among clinical forms were not statistically significant. The detection rate of AHSV was compared according to the month in which clinical cases were reported and samples were collected. The highest detection rate was recorded in November (36.4%), followed by December (22.2%) and January (11.1%), while no AHSV-positive samples were detected in February. Except for age, none of the evaluated variables, including season, showed a statistically significant association with AHSV detection (P > 0.05). The lack of a significant seasonal association may be attributed to factors such as the small sample size, timing of sample collection within the epidemic cycle, and the diagnostic methods employed (Table 2). Table 2Summary result of Conventional RT- PCR test with respect to different risk factors.Table 2 dummy alt textVariablesNo. of EquidsAHS positive (%)correctedX2/Fishers ExactP-valueSpecies Donkey82 (25%)0.0610.805 Horse244 (20.8%)Sex Female103 (30%)0.5620.454 Male224 (18.2%)Age group (years) ≤490 (0) 4-10151 (6.67%)17.7620.001 ->1086(75%)District Jima102(20%) Arsi Negele82 (25%)0.139 Moretina Juru50 (0) Bale Gorro30 (0) Adulaala22(100) Kembibit(sheno)21 (50) Yabello20 (0)Forms of disease sign Mixed154 (26.67%) Cardiac80 (0)0.299 Subclinical62 (33.3%) Pulmonary31 (33.3%)Season November114 (36.36%) December92 (22.22%)0.721 January91 (11.11%) February30 (0) Summary result of Conventional RT- PCR test with respect to different risk factors. AHSV serotyping Seven AHSV-positive samples identified using universal primers were further tested by RT-PCR targeting the VP2 gene (segment 2) to detect serotypes 2, 4, and 9 using serotype-specific primers. Other serotypes were not included due to regional epidemiology, previous reports, and diagnostic constraints. The assay produced two strong amplicons of approximately 228bp, confirming the presence of AHSV serotype 9 (AHSV-9), which was detected only in tissue samples (lung and spleen). The remaining five positive samples showed no amplification for serotypes 2, 4, or 9, indicating that they likely belonged to other serotypes (Fig. 4). Agarose gel electrophoresis of RT-PCR products targeting AHSV segment 2 showing no amplification in blood samples (lanes 1-5) and 228bp serotype 9 bands in tissue samples (lanes 6-7). Lanes 8-9 are positive controls, 10-11 negative controls, and M is the molecular marker. Cytopathic effect on Vero cell lines In cell culture, the cytopathic effect (CPE) of AHSV was characterized by cell refractivity and detachment. Seven RT-PCR-positive samples were inoculated onto Vero cell monolayers, and virus isolation was successful from lung and spleen tissues, with CPE observed after seven days post–second blind passage. After three blind passages, a distinct CPE was evident, characterized by cell rounding, aggregation of dead cells, detachment from the monolayer, and complete monolayer destruction (fig. 5). All samples underwent three serial passages; cultures showing no CPE were considered negative, while positive cultures were confirmed by conventional RT-PCR using universal primers. CPE in Vero cells infected with AHSV serotype 9 isolates from spleen and lung tissues, showing cell refractivity, aggregation, and monolayer destruction compared with intact control cells (A-B). Discussion African horse sickness is a non-contagious but economically devastating disease of equines, typically presenting with severe respiratory distress, high fever, dyspnea, hyperemic conjunctiva, and swelling of the head region. During this study, different clinical forms were observed, including per-acute (pulmonary), subacute (cardiac), acute, and mixed forms, with postmortem and clinical findings consistent with earlier reports (Gomez-Villamandos et al., 1999; Guthrie et al., 2013; Coetzer & Guthrie, 2017; Bunpapong et al., 2020). This study aimed to isolate and characterize circulating AHSV serotypes using OIE-recommended molecular diagnostic techniques, including Vero cell culture and conventional RT-PCR (OIE (World Organization of Animal Health), 2019; Rinzin et al., 2023). Virus isolation was successful from tissue samples, aligning with the findings by Ayelet et al., (2014), while molecular detection confirmed 21.86% positivity, demonstrating RT-PCR as a rapid, sensitive, and specific diagnostic tool compared to virus isolation. The molecular detection rate observed in this study was relatively lower compared with previous reports by Aklilu et al., (2014) and Ayele et al., (2014), partly may be attributed to prior vaccination of equines in outbreak areas. Vaccination can reduce viral replication, shorten the duration of viraemia, and decrease viral load in blood and tissues, thereby lowering the likelihood of detecting viral RNA, particularly when samples are collected late in the course of infection. In addition, vaccinated animals may exhibit milder clinical signs and reduced virus circulation, which can affect the sensitivity of molecular assays and contribute to lower detection rates during field investigations (Adesola et al., 2023; Baylis et al., 1999; NVI, 2019). The PCR analysis successfully amplified the virus VP7 encoding gene and resulted in a single major band of approximately 102bp fragments of dsDNA on agarose gels based on Fernandez-Pinero et al., (2009) which revealed that the equines were infected with AHS virus. This PCR finding was in agreement with the previous report of Aklilu et al., (2014) and Ayelet et al., (2014) and the same PCR product band size obtained. According to the current findings, despite the fact that the majority of clinical findings in affected equines were suggestive of AHS, no amplified products of cDNA were detected in reactions with the other 25 blood samples. The level of viremia might be low that the detection of AHSV genome was negative. The presence of large levels of RNases protein, very low (insufficient amount of virus particles), and various PCR inhibitors might influence the negative outcome (Stringer et al., 2015; Schliewert et al., 2022). With the exception of age, there was no statistically significant difference in the presence of AHS based on all considered risk factors. The study revealed a significant variation on infection with AHSV among the three age groups. High infection rate in old age group mainly due to excessive administration of vaccine over many years lead to a state of immunological unresponsiveness or hypersensitivity (Gordon et al., 2013, Maureen et al., 2014). This finding was in line with studies conducted in Sudan by Ahmed et al., (2020), but it contradicted with the previous study of Burrage et al. (1994) in which host factors such as age, sex and body condition have no influence on the susceptibility to AHS in naive horses. In the present study, the infection rate of AHSV was not determined in sex groups of Equines that was in line with Burrage et al. (1994) and Rinzin and his coworkers (2023). The finding of the present study showed that the association between type of Equine and season with AHS Viral infection were not statistically significant. This finding was not in agreement with Rodríguez et al., (2020) and WOAH (2020) in which the highest incidence of the disease was reported in late summer and early autumn. They also stated that horses were the most susceptible species to AHS with a mortality rate of 50-95%. Study design, sample size and sampling time (epidemic cycle) may affect the association between occurrence of AHS with in species and season in these study areas (Mourits, 2012; Rodríguez et al., 2020; WOAH, 2020). The occurrence of AHSV across the study districts also revealed that the disease is endemic in different agro-ecological conditions, which was supported by Adesola et al. (2023) and Hanekom and others (2023). The current molecular serotyping investigation confirmed AHSV serotype 9 in tissues samples with a PCR product size of 228bp (O'Dell et al,. 2018). This finding showed strong agreement with previous studies; stating that AHSV serotype 9 is the most prevalent serotype in Ethiopia (Ayelet et al., 2014; Zeleke et al., 2005) and the majority of outbreaks were caused by AHS serotype 9 (Aklilu et al., 2014; Hanekom et al., 2023). In the current study, virus isolation results that only two tissues samples showed CPE results on vero cell line. All the samples from blood found to be negative to the cell culture and a similar finding was also reported by Hanekom and others (2023). A negative result of CPE from blood samples might be due the stage of the disease course during sampling, time and storage conditions and the presence of inactivated or low live virus load to induce multiplication in the cell line (OIE (World Organization of Animal Health), 2019). Manuel and his co-authors (2025) and Weyer (2021) also found that tissue samples were able to show CPE characteristics as compared to the results obtained from the blood samples. The present and the previous findings showed that tissues are more preferable for virus isolation with similar findings like (Gao et al., 2022; Schliewert et al., 2022) and this is more likely because of the existence of high virus load in the clinical tissue samples. This study also demonstrates the combined use of molecular detection and virus isolation enhanced the confirmation of African horse sickness virus (AHSV) infection by providing both sensitive viral RNA detection and recovery of infectious virus. While RT-PCR offers rapid and highly sensitive diagnosis, virus isolation provides definitive evidence of active infection and enables further characterization of circulating strains. The successful isolation of AHSV from clinical tissue samples in this study is noteworthy, as recent reports of virus isolation from Ethiopian outbreaks are limited. Compared with previous studies that relied primarily on molecular detection, the present work provides additional epidemiological and virological evidence of AHSV circulation. Furthermore, the generation of contemporary outbreak-associated data contributes to filling important knowledge gaps regarding circulating AHSV strains in Ethiopia and supports improved surveillance, control, and future molecular epidemiological investigations in line with Dennis et al., 2019, Long & Guthrie, 2014 and Karamalla et al. (2020) . The detection of AHSV in the present study supports previous evidence that AHS remains endemic in Ethiopia and continues to pose a significant risk to equine populations. Similar to earlier reports, the occurrence of outbreaks in different regions suggests sustained virus circulation, likely facilitated by the widespread distribution of Culicoides vectors and favorable environmental conditions during rainy seasons. Previous studies have documented the circulation of multiple serotypes, including AHSV-2, -4, -6, -8, and -9, with serotype 9 being most frequently associated with outbreaks in Ethiopia (Aklilu et al., 2014; Ayelet et al., 2014; Zeleke et al., 2005). The current findings reinforce concerns regarding the continued potential for AHS outbreaks and highlight the importance of enhanced molecular surveillance, routine serotyping, and epidemiological monitoring to improve disease prevention and control strategies in Ethiopia. Conclusion and recommendations African Horse Sickness is one of the leading constraints for the productivity and welfare of equines, which results in significant socio-economic impacts to the country. The present study reveals relatively high prevalence of circulating AHSV in different study areas. This study also revealed that AHSV serotype 9 was confirmed using molecular and virological technique, and known to circulate in Liben Zikuala districts and causes the most severe respiratory and circulatory impairment, which results in death of horses. Based on this finding, the following recommendations were forwarded: ✓Strategic vaccination is required to prevent and control outbreak of AHS diseases in endemic areas. Strategic vaccination is required to prevent and control outbreak of AHS diseases in endemic areas. ✓Further investigation should be undertaken to confirm molecular detection of AHSV in areas where there is no information on the epidemiology of the disease so that better control will be possible. Further investigation should be undertaken to confirm molecular detection of AHSV in areas where there is no information on the epidemiology of the disease so that better control will be possible. ✓Detail epidemiological investigations and characterization of the virus from the vector and wild animals should be practiced. Detail epidemiological investigations and characterization of the virus from the vector and wild animals should be practiced. Limitation of the study The relatively small sample size (n = 32) is because of the outbreak-based sampling approach In addition, complete serotyping was not achieved, as five of seven AHSV-positive samples remained untyped, and genomic sequencing was not performed to confirm strain identity or investigate molecular epidemiological relationships due to unavailability of resources. Furthermore, vaccination history was unavailable for the studied animals, restricting assessment of potential vaccine-related effects on disease occurrence and laboratory findings. The authors recommend further comprehensive studies. Despite these limitations, the study provides valuable contemporary data on AHSV circulation in Ethiopia. Ethics approval and consent to participate Ethical clearance for the study was granted by the Animal Research Ethical Review Committee of Addis Ababa University, College of Veterinary Medicine and Agriculture, Bishoftu, Ethiopia (Reference No. VM/ERC/33/06/13/2021), in accordance with international guidelines for animal welfare and ethics. All animal sampling was conducted following the experimental practices and standards approved by this committee. Informed consent was obtained from all owners through verbal communication, and all owners of the animals were fully volunteers to take samples and conduct other findings from their animals. Statement for studies in humans/animals Ethical clearance for the study was granted by the Animal Research Ethical Review Committee of Addis Ababa University, College of Veterinary Medicine and Agriculture, Bishoftu, Ethiopia (Reference No. VM/ERC/33/06/13/2021), in accordance with international guidelines for animal welfare and ethics. All animal sampling was conducted following the experimental practices and standards approved by this committee. Informed consent was obtained from all owners through verbal communication, and all owners of the animals were fully volunteers to take samples and conduct other findings from their animals. Funding There is no funding organization for this manuscript. It is self-supported. CRediT authorship contribution statement Degu Fhetanegest Esey: Writing – original draft, Methodology, Investigation, Formal analysis, Conceptualization. Hika Waktole: Supervision, Software, Resources, Investigation, Funding acquisition. Esayas Gelaye: Writing – review & editing, Supervision, Methodology. Dessalew Habte Alene: Writing – review & editing, Methodology, Conceptualization. Habtamu Addis Minale: Writing – review & editing. Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.